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LETTERS
Obesity in patients with COPD, an
undervalued problem?
Franssen et al reported potential links
between obesity and chronic obstructive
pulmonary disease (COPD).1 In their review,
the authors use obesity prevalence estimates
for COPD patient populations from only
two studies with a relatively small sample
sizes.2 3 Therefore, in our view, whether or
not obesity is actually more prevalent in
patients with COPD is still a matter of
debate. Moreover, the current evidence of a
possible association between obesity and a
worse COPD disease state is inconclusive.
This information is crucial before consider-
ing any potential underlying mechanisms of
this presumed association.
In order to contribute to the discussion on
the role of obesity in COPD, we analysed
data from a Dutch regional primary care
diagnostic centre to address these questions.
The procedures and database have been
described elsewhere.4 In short, our database
contains spirometry tests of patients
referred by general practitioners. Also infor-
mation on body mass index (BMI), smoking
habits, exacerbation rate and level of dys-
pnoea (Medical Research Council (MRC)
score) are collected during all visits.4 For the
current analysis, we used information from
the most recent spirometric tests from all
current and former smokers with respiratory
symptoms aged .40 years and a post-
bronchodilator forced expiratory volume in
1 s (FEV1)/forced vital capacity (FVC) of
,0.70. BMI (kg/m2) was categorised as low
weight (BMI (21), normal weight ((21,
BMI ,25), overweight (25( BMI ,30) and
obesity (BMI >30). Obese patients were
compared with normal and overweight
patients in terms of postbronchodilator
FEV1% predicted, FVC and MRC scores.
The associations between obesity and these
outcomes were analysed with linear regres-
sion and ordinal regression. The models
were corrected for age, gender and current
smoking habit.
Table 1 shows the characteristics of the
study population (n = 1761) by BMI cate-
gory. Overall, 15.1% of the study subjects
were obese. FVC was 250 ml lower in obese
patients compared with patients with nor-
mal weight and overweight (p,0.01). We
found no association between obesity and
post-FEV1% predicted, but obesity was
associated with higher MRC scores (odds
ratio (OR) 2.05, 95% CI 1.67 to 2.52).
The prevalence of obesity in our popula-
tion was lower compared with the study by
Steuten et al (ie, 18%), but still slightly
higher compared with the general Dutch
population aged >45.5 Only the FVC was
reduced in the obese COPD patients. This is
an important observation, as this could
result in under-representation of COPD in
obese individuals when the main GOLD
(Global Initiative for Chronic Obstructive
Lung Disease) criterion (ie, FEV1/FVC,0.70)
is applied to demonstrate airflow obstruc-
tion.
Although our findings indicate that the
prevalence of obesity in patients with COPD
is only slightly higher compared with that of
the general population, obesity is a prevalent
problem in patients with COPD associated
with a higher level of dyspnoea. Therefore,
we ask for more attention to be paid to
obesity in patients with COPD, in both
research and patient care. Our efforts should
focus not only on research into potential
links between obesity and COPD, but also
on effective ways to prevent and treat
obesity in COPD patients, which may
require a different approach from that in in
healthy subjects.
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Authors’ reply
We welcome the comments of van den Bemt
et al regarding our review on obesity and
chronic obstructive pulmonary disease
(COPD). Their careful analysis of a large
Dutch primary care population of COPD
provides further evidence for an increased
prevalence of obesity in patients with early-
stage COPD. According to their data, about
17% of the patients in GOLD (Global
Initiative for Chronic Obstructive Lung
Disease) stage II are obese vs 11% in a
healthy Dutch population.1 The prevalence
of a body mass index (BMI) >30 kg/m2 was
significantly lower in GOLD III (14%) and
substantially reduced in GOLD IV patients
(2%). The results of van den Bemt et al
furthermore show that obesity is clinically
important in COPD patients, since it is
related to increased dyspnoea. Although the
association between BMI and breathlessness
is not unique for patients with COPD,2 it
indicates that the abundance of fat mass is a
factor that should be taken into account in
COPD management. Based on the existing
prevalence data, the authors urge for
research to be carried out into effective
prevention and intervention strategies of
Table 1 Characteristics of the study population by body mass index (BMI) category
Low weight Normal weight Overweight Obesity
BMI (21
(n = 222)
BMI 21.01–24.99
(n = 583)
BMI 25–29.99
(n = 690)
BMI >30
(n = 266)
Age* 60.3 (11.2) 62.2 (10.7) 63.9 (10.3) 63.6 (10.0)
Gender (male) 104 (46.8) 363 (62.3) 497 (72.0) 168 (63.2)
Current smoker 154 (69.4) 331 (56.8) 289 (41.9) 111 (41.7)
GOLD stages
I 32 (14.4) 89 (15.3) 91 (13.2) 22 (13.3)
II 100 (45.0) 362 (62.1) 440 (63.8) 187 (70.3)
III or IV 90 (40.6) 132 (22.6) 159 (23.1) 57 (21.5)
MRC score
0 55 (24.8) 211 (36.2) 215 (31.2) 46 (17.3)
1 92 (41.4) 238 (40.8) 277 (40.1) 114 (42.9)
2–4 75 (33.8) 134 (23.0) 198 (28.8) 106 (39.8)
Postbronchodilator lung
function
FEV1% predicted{ 56.5 (18.2) 63.0 (16.8) 62.7 (16.2) 61.1 (13.4)
FVC (litres){ 3.2 (0.96) 3.4 (1.00) 3.4 (1.00) 3.1 (0.92)
FEV1/FVC{ 0.54 (0.11) 0.57 (0.10) 0.59 (0.09) 0.62 (0.07)
Figures are number and percentage unless stated otherwise.
*All differences between groups were significant (p,0.01). {Mean (SD).
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease;
MRC, Medical Research Council.
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